Work

The Role of Pharmacy Benefit Managers in Access to Biologics for Dermatologic Conditions

Year: 2025

Type: article

Abstract: In this commentary, we discuss the role of pharmacy benefit managers (PBMs) on access to biologics for patients with psoriasis. We highlight structural and system level barriers to biologics access, as well as how PBMs work as intermediaries between insurers, pharmacies, and drug manufactures to influence prescription formularies and generate health savings. We also discuss how controversial PBM practices such as step therapy, prior authorizations, and spread pricing may limit access to biologics and potentially increase cost for patients. Finally, we highlight how dermatologists and national organizations such as the National Psoriasis Foundation can collaborate and advocate for legislative reforms to increase transparency among PBMs.

Source: Journal of Psoriasis and Psoriatic Arthritis

DOI: 10.1177/24755303251387126

Authors: Melissa C. Leeolou, Justin L. Jia, Jason Harris, Wilson Liao

Institutions: Stanford Medicine, Stanford University, National Psoriasis Foundation, University of California, San Francisco

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4415425532

FWCI:

Cites: 3

Cited by:

Related to: